Fitish vs HealthSource
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
People who prioritize a verified pharmacy and oral options over finding the lowest rate.
- semaglutide
- $219/mo
- tirzepatide
- $339/mo
FDAWarning letter issued to FITISH in June 2026. See the FDA warning-letter database.
Before enrolling
Higher pricing than the value leaders
Desk Score
Compounded semaglutide or tirzepatide, by weekly injection or as a nightly tablet, in all 50 states from $199 every four weeks.
- semaglutide
- $199 per 4 weeks
- tirzepatide
- $299 per 4 weeks
Before enrolling
You pay before the medical intake — the questionnaire link appears only after checkout, and withdrawing once you have filled it in costs you $25–$45 for the provider review
Our review of Fitish gives it 86/100 (B), while our review of HealthSource gives it 84/100 (B). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
86/100
B
84/100
B
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | Fitish | HealthSource |
|---|---|---|
| Semaglutide | $219/moFull plan terms$219/mo | $199 per 4 weeksFull plan terms$199 every 4 weeks month-to-month (13 charges a year, all doses, compounded) |
| Tirzepatide | $339/moFull plan terms$339/mo | $299 per 4 weeksFull plan terms$299 every 4 weeks month-to-month (13 charges a year, all doses, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name | Not confirmed here | Not confirmed here |
| Oral option | Oral option listed | Oral option listed |
| Best for | People who prioritize a verified pharmacy and oral options over finding the lowest rate. | Compounded semaglutide or tirzepatide, by weekly injection or as a nightly tablet, in all 50 states from $199 every four weeks. |
| Desk Score | 86/100B | 84/100B |
The verdict
Desk pick — FitishFitish has the higher Desk Score, but HealthSource may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
People who prioritize a verified pharmacy and oral options over finding the lowest rate.
FDAWarning letter issued to FITISH in June 2026. See the FDA warning-letter database.
Compounded semaglutide or tirzepatide, by weekly injection or as a nightly tablet, in all 50 states from $199 every four weeks.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs Fitish
- CoreAge Rx vs HealthSource
- Curex vs Fitish
- Curex vs HealthSource
- BetterMe Rx vs Fitish
- BetterMe Rx vs HealthSource
Or see the full comparison hub and the complete ranking.